Hung TH, Tsai CC, Tsai CC, Tseng CW, Hsieh YH
Correspondence: Dr Yu-Hsi Hsieh, hsieh.yuhsi@msa.hinet.net
ABSTRACT
INTRODUCTION Necrotising fasciitis (NF) is often found in patients with diabetes mellitus, chronic renal failure, alcoholism, malignancy or liver cirrhosis. However, it remains unknown whether liver cirrhosis is an independent risk factor for the occurrence of NF. This study aimed to determine whether liver cirrhosis is an independent risk factor for the occurrence of NF, and to identify the relationship between severity of liver cirrhosis and occurrence of NF.
METHODS The National Health Insurance Research Database, maintained by Taiwan’s National Health Insurance programme, was retrospectively analysed, and the hospitalisation data of 40,802 cirrhotic patients and 40,865 randomly selected, age? and gender?matched non?cirrhotic control patients was collected. The medical records of all patients were individually followed for a three?year period from the patients’ first hospitalisation in 2004.
RESULTS During the three?year follow?up period, there were 299 (0.7%) cirrhotic patients with NF and 160 (0.4%) non?cirrhotic patients with NF. Cox regression analysis showed that liver cirrhosis was a risk factor for the occurrence of NF during the study period (hazard ratio 1.982; p < 0.001). Among cirrhotic patients, those with complicated liver cirrhosis had a higher risk for the occurrence of NF than patients with non?complicated liver cirrhosis (hazard ratio 1.320; p = 0.028).
CONCLUSION Cirrhotic patients had a higher risk for the occurrence of NF than non?cirrhotic patients, and the risk for NF was especially high among patients with complicated liver cirrhosis.
Keywords: cirrhosis, complicated liver cirrhosis, necrotising fasciitis
Singapore Med J 2014; 55(7): 378-382; http://dx.doi.org/10.11622/smedj.2014090
REFERENCES
1. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005; 140:151?7. http://dx.doi.org/10.1001/archsurg.140.2.151 | ||||
2. Lee CC, Chi CH, Lee NY, et al. Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram?negative bacillary infections. Diagn Microbiol Infect Dis 2008; 62:219?25. http://dx.doi.org/10.1016/j.diagmicrobio.2008.05.016 | ||||
3. Huang KF, Hung MH, Lin YS, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma 2011; 71:467?73. http://dx.doi.org/10.1097/TA.0b013e318220d7fa | ||||
4. Bair MJ, Chi H, Wang WS, et al. Necrotizing fasciitis in southeast Taiwan: clinical features, microbiology, and prognosis. Int J Infect Dis 2009; 13:255?60. http://dx.doi.org/10.1016/j.ijid.2008.04.015 | ||||
5. Christou L, Pappas G, Falagas ME. Bacterial infection?related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007; 102:1510?7. http://dx.doi.org/10.1111/j.1572-0241.2007.01286.x | ||||
6. Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140?8. http://dx.doi.org/10.1053/jhep.2002.30082 | ||||
7. Cheng NC, Tai HC, Tang YB, et al. Necrotising fasciitis: clinical features in patients with liver cirrhosis. Br J Plast Surg 2005; 58:702?7. http://dx.doi.org/10.1016/j.bjps.2005.01.019 | ||||
8. Hung CC, Chang SC, Lin SF, et al. Clinical manifestations, microbiology and prognosis of 42 patients with necrotizing fasciitis. J Formos Med Assoc 1996; 95:917?22. PMid:9000808 | ||||
9. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007; 40:381?7. http://dx.doi.org/10.1038/sj.bmt.1705727 | ||||
10. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995?1999. Clin Infect Dis 2002; 35:268?76. http://dx.doi.org/10.1086/341409 | ||||
11. Kaul R, McGeer A, Low DE, et al. Population?based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy?seven cases. Ontario Group A Streptococcal Study. Am J Med 1997; 103:18?24. http://dx.doi.org/10.1016/S0002-9343(97)00160-5 | ||||
12. Baxter F, McChesney J. Severe group A streptococcal infection and streptococcal toxic shock syndrome. Can J Anaesth 2000; 47:1129?40. http://dx.doi.org/10.1007/BF03027968 | ||||
13. Eneli I, Davies HD. Epidemiology and outcome of necrotizing fasciitis in children: an active surveillance study of the Canadian Paediatric Surveillance Program. J Pediatr 2007; 151:79?84. http://dx.doi.org/10.1016/j.jpeds.2007.02.019 | ||||
14. Hsu HC, Lin WS, Tsai MJ. Hepatitis?B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells. Cancer 1983; 52:1825?32. http://dx.doi.org/10.1002/1097-0142(19831115)52:10<1825::AID-CNCR2820521011>3.0.CO;2-M | ||||
15. Tsai JF, Chang WY, Jeng JE, et al. Hepatitis C virus infection as a risk factor for non?alcoholic liver cirrhosis in Taiwan. J Med Virol 1993; 41:296?300. http://dx.doi.org/10.1002/jmv.1890410407 | ||||
16. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85?A:1454?60. | ||||
17. Lin C, Yeh FL, Lin JT, et al. Necrotizing fasciitis of the head and neck: an analysis of 47 cases. Plast Reconstr Surg 2001; 107:1684?93. http://dx.doi.org/10.1097/00006534-200106000-00008 | ||||
18. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest 1996; 110:219?29. http://dx.doi.org/10.1378/chest.110.1.219 | ||||
19. McHenry CR, Piotrowski JJ, Petrinic D, et al. Determinants of mortality for necrotizing soft?tissue infections. Ann Surg 1995; 221:558?63. http://dx.doi.org/10.1097/00000658-199505000-00013 | ||||
20. Shimizu T, Tokuda Y. Necrotizing fasciitis. Intern Med 2010; 49:1051?7. http://dx.doi.org/10.2169/internalmedicine.49.2964 | ||||
21. Mulla ZD. Streptococcal myositis. Br J Plast Surg 2003; 56:424. http://dx.doi.org/10.1016/S0007-1226(03)00129-2 | ||||
22. Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen?year retrospective study of 163 consecutive patients. Am Surg 2002; 68:109?16. PMid:11842952 | ||||
23. Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996; 224:672?83. http://dx.doi.org/10.1097/00000658-199611000-00011 | ||||
24. Lamagni TL, Darenberg J, Luca?Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46:2359?67. http://dx.doi.org/10.1128/JCM.00422-08 | ||||
25. Murphy JJ, Granger R, Blair GK, et al. Necrotizing fasciitis in childhood. J Pediatr Surg 1995; 30:1131?4. http://dx.doi.org/10.1016/0022-3468(95)90004-7 | ||||
26. Nuwayhid ZB, Aronoff DM, Mulla ZD. Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol 2007; 17:878?81. http://dx.doi.org/10.1016/j.annepidem.2007.05.011 | ||||
27. Headley AJ. Necrotizing soft tissue infections: a primary care review. Am Fam Physician 2003; 68:323?8. PMid:12892352 | ||||
28. Garcia?Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004; 18:353?72. http://dx.doi.org/10.1016/j.bpg.2003.10.005 | ||||
29. Galati JS, Holdeman KP, Bottjen PL, et al. Gastric emptying and orocecal transit in portal hypertension and end?stage chronic liver disease. Liver Transpl Surg 1997; 3:34?8. http://dx.doi.org/10.1002/lt.500030105 | ||||
30. Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003; 98:1362?70. http://dx.doi.org/10.1111/j.1572-0241.2003.07475.x | ||||
31. Riordan SM, Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol 2006; 45:744?57. http://dx.doi.org/10.1016/j.jhep.2006.08.001 | ||||
32. Wiest R, Garcia?Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41:422?33. http://dx.doi.org/10.1002/hep.20632 | ||||
33. Fierer J, Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest 1979; 63:912?21. http://dx.doi.org/10.1172/JCI109391 | ||||
34. Garcia?González M, Boixeda D, Herrero D, et al. Effect of granulocyte?macrophage colony?stimulating factor on leukocyte function in cirrhosis. Gastroenterology 1993; 105:527?31. | ||||
35. Mellencamp MA, Preheim LC. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis 1991; 163:102?8. http://dx.doi.org/10.1093/infdis/163.1.102 | ||||
36. Homann C, Varming K, Høgåsen K, et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997; 40:544?9. PMid:9176087 PMCid:PMC1027133 | ||||
37. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4:53?8. http://dx.doi.org/10.1002/hep.1840040109 | ||||
38. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33:41?8. http://dx.doi.org/10.1016/S1590-8658(01)80134-1 | ||||
39. Thulstrup AM, Sørensen HT, Schønheyder HC, et al. Population?based study of the risk and short?term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 2000; 31:1357?61. http://dx.doi.org/10.1086/317494 | ||||
40. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003; 124:1016?20. http://dx.doi.org/10.1378/chest.124.3.1016 | ||||
41. Kuo CH, Changchien CS, Yang CY, et al. Bacteremia in patients with cirrhosis of the liver. Liver 1991; 11:334?9. http://dx.doi.org/10.1111/j.1600-0676.1991.tb00539.x |